Actelion (OTCMKTS:ALIOF) and China Jo-Jo Drugstores (NASDAQ:CJJD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.
Institutional & Insider Ownership
18.1% of China Jo-Jo Drugstores shares are held by institutional investors. 34.9% of China Jo-Jo Drugstores shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This table compares Actelion and China Jo-Jo Drugstores’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|China Jo-Jo Drugstores||-16.53%||-86.38%||-24.13%|
This is a summary of current ratings for Actelion and China Jo-Jo Drugstores, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|China Jo-Jo Drugstores||0||0||0||0||N/A|
Volatility & Risk
Actelion has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, China Jo-Jo Drugstores has a beta of -0.08, suggesting that its share price is 108% less volatile than the S&P 500.
Earnings and Valuation
This table compares Actelion and China Jo-Jo Drugstores’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Actelion||$2.46 billion||0.00||$707.04 million||N/A||N/A|
|China Jo-Jo Drugstores||$96.11 million||0.66||-$17.05 million||N/A||N/A|
Actelion has higher revenue and earnings than China Jo-Jo Drugstores.
Actelion beats China Jo-Jo Drugstores on 6 of the 8 factors compared between the two stocks.
Actelion Ltd. is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of low molecular weight drugs. It specializes in the field of pulmonary arterial hypertension (PAH). It also specializes in human biology, especially in specific families of molecular targets, such as G-Protein Coupled Receptors. Its portfolio of PAH treatments covers the spectrum of disease, from World Health Organization (WHO) Functional Class (FC) II through to Functional Class (FC) IV, with oral, inhaled and intravenous medications. It also has treatments for a range of specialist diseases, including type 1 Gaucher disease, Niemann-Pick type C disease, digital ulcers in patients suffering from systemic sclerosis and mycosis fungoides type cutaneous T-cell lymphoma. Its products include Tracleer (bosentan), Opsumit (macitentan), Uptravi (selexipag), Ventavis (iloprost), Veletri (epoprostenol for injection), Zavesca (miglustat) and Valchlor (mechlorethamine) gel.
About China Jo-Jo Drugstores
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM onsite for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates dada360.com, an online drugstore that retails OTC drugs and nutritional supplements. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2018, it had 122 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as operates 9 drugstores under the Jiuzhou Grand Pharmacy name in Zhejiang Province. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China.
Receive News & Ratings for Actelion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Actelion and related companies with MarketBeat.com's FREE daily email newsletter.